Vera Therapeutics, Inc.
27.99USD
-1.0600 (-3.65%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on VERA.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | -$1.61▼ | -$1.54 | 1 | 0 |
| Next quarter | -$1.54▼ | -$1.41 | 0 | 1 |
| Current year | -$6.25▼ | -$6.21 | 1 | 1 |
| Next year | -$4.25▼ | -$3.86 | 1 | 1 |
Beat in 1 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | -$1.59 | -$1.52 | +0.07 (+4.4%) |
| 2026-03-31 | -$1.37 | -$1.69 | -0.32 (-23.0%) |
| 2025-12-31 | -$1.27 | -$1.39 | -0.12 (-9.7%) |
| 2025-09-30 | -$1.13 | -$1.26 | -0.13 (-11.7%) |
77 ratings from 17 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Leerink Partners | Initiated | Market Perform | $34 | Oct 12, 2026 |
| JP Morgan | Maintained | Overweight | $76 $83 | Sep 8, 2026 |
| Wedbush | Reiterated | Neutral | $34 | Aug 17, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $125 $90 | Aug 12, 2026 |
| Wedbush | Maintained | Neutral | $43 $34 | Aug 11, 2026 |
| TD Cowen | Maintained | Buy | $73 $78 | Jul 8, 2026 |
| Guggenheim | Maintained | Buy | $56 $76 | Jul 8, 2026 |
| Wedbush | Maintained | Neutral | $35 $43 | Jul 8, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $110 $125 | Jul 8, 2026 |
| B of A Securities | Maintained | Buy | $65 $70 | Jul 7, 2026 |
| Evercore ISI Group | Maintained | Outperform | $95 $91 | May 15, 2026 |
| Wolfe Research | Upgraded from Peer Perform | Outperform | $88 | Mar 11, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $90 $110 | Mar 2, 2026 |
| B of A Securities | Maintained | Buy | $48 $66 | Dec 19, 2025 |
| Goldman Sachs | Maintained | Buy | $55 $95 | Dec 19, 2025 |
| JP Morgan | Maintained | Overweight | $99 $96 | Dec 19, 2025 |
| Wedbush | Maintained | Neutral | $23 $33 | Dec 11, 2025 |
| Evercore ISI Group | Maintained | Outperform | $75 $97 | Dec 8, 2025 |
| TD Cowen | Maintained | Buy | $60 $73 | Dec 5, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $85 $90 | Nov 10, 2025 |
| JP Morgan | Maintained | Overweight | $53 $52 | Nov 7, 2025 |
| B of A Securities | Initiated | Buy | $48 | Oct 16, 2025 |
| JP Morgan | Maintained | Overweight | $56 $53 | Aug 7, 2025 |
| Wolfe Research | Downgraded from Outperform | Peer Perform | — | Aug 4, 2025 |
| Scotiabank | Maintained | Sector Outperform | $55 $65 | Jun 2, 2025 |
73 filings from 14 insiders · 7 buy / 8 sell over 6m
Officers and directors of VERA, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Fordyce MarshallDirector; Officer, PRESIDENT AND CEO | Exercise | 18.5k | $2.90 | $54k | Sep 15, 2026 |
| Fordyce MarshallDirector; Officer, PRESIDENT AND CEO | Sell | 18.5k | $37.00 | $685k | Sep 15, 2026 |
| Fordyce MarshallDirector; Officer, PRESIDENT AND CEO | ExerciseStock Option (Right to Buy) | 18.5k | — | — | Sep 15, 2026 |
| Young Joseph ROfficer, SVP, FINANCE, CHIEF ACCT OFFCR | Exercise | 5.0k | $3.94 | $20k | Sep 11, 2026 |
| Young Joseph ROfficer, SVP, FINANCE, CHIEF ACCT OFFCR | ExerciseStock Option (right to buy) | 5.0k | — | — | Sep 11, 2026 |
| Fordyce MarshallDirector; Officer, PRESIDENT AND CEO | Exercise | 18.5k | $2.90 | $54k | Sep 2, 2026 |
| Fordyce MarshallDirector; Officer, PRESIDENT AND CEO | Sell | 18.5k | $35.12 | $650k | Sep 2, 2026 |
| Fordyce MarshallDirector; Officer, PRESIDENT AND CEO | ExerciseStock Option (Right to Buy) | 18.5k | — | — | Sep 2, 2026 |
| BOMAN NANCY LEE M.D., PH.D.Officer | Grant | 45.0k | — | — | Aug 3, 2026 |
| FORDYCE MARSHALLChief Executive Officer | Sell | 46.3k | $40.78 | $1.96M | Jul 7, 2026 |
| FORDYCE MARSHALLChief Executive Officer | Exercise | 46.3k | $2.90 | $134k | Jul 7, 2026 |
| FORDYCE MARSHALLChief Executive Officer | Sell | 18.5k | $37.93 | $702k | Jun 23, 2026 |
| FORDYCE MARSHALLChief Executive Officer | Exercise | 18.5k | $2.90 | $54k | Jun 23, 2026 |
| FORDYCE MARSHALLChief Executive Officer | Sell | 18.5k | $36.64 | $680k | May 12, 2026 |
| FORDYCE MARSHALLChief Executive Officer | Exercise | 18.5k | $2.90 | $54k | May 12, 2026 |
| FORDYCE MARSHALLChief Executive Officer | Sell | 23.0k | $43.66 | $1.01M | Apr 14, 2026 |
| WRIGHT-MITCHELL CATHERINE JANEOfficer | Grant | 42.4k | — | — | Mar 23, 2026 |
| YOUNG JOSEPH ROfficer | Exercise | 10.0k | $3.94 | $39k | Mar 13, 2026 |
| TURNER WILLIAM DONALDOfficer | Sell | 2.2k | $41.98 | $92k | Feb 23, 2026 |
| FORDYCE MARSHALLChief Executive Officer | Sell | 16.9k | $41.98 | $711k | Feb 23, 2026 |
No analyst notes on VERA yet.
Members whose judged calls on VERA have played out most reliably.
No settled calls on VERA yet. Nobody has filed a call with a deadline on it.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice
Analyst Ratings
15 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 1 | 12 | 2 | 0 | 0 | Buy2.07 |
| 1 mo ago | 1 | 12 | 1 | 0 | 0 | Buy2.00 |
| 2 mo ago | 1 | 12 | 1 | 0 | 0 | Buy2.00 |
| 3 mo ago | 1 | 12 | 1 | 0 | 0 | Buy2.00 |